Latest Regulatory Changes News

Helia Group reveals ING Bank Australia will not renew its Lenders Mortgage Insurance contract beyond June 2026, prompting a strategic business review amid evolving market dynamics.

Oceania Healthcare’s CEO delivered a confident first AGM address highlighting robust sales growth, operational efficiencies, and a refreshed strategic vision focused on care quality and sustainability.

Delorean Corporation stands to benefit significantly from recent Australian regulatory reforms that formally recognise biomethane as a natural gas equivalent, enhancing the commercial viability of its renewable gas projects.

Metcash Limited reported solid FY25 financial results with revenue growth and market share gains across key pillars, underpinned by strategic acquisitions and operational improvements. The company enters FY26 with positive momentum and ongoing transformation initiatives.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.1405 per security on its PERLS XIII capital note, payable mid-September 2025.

Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.

EDU Holdings reports a remarkable 118% increase in total student enrolments at its Ikon Institute for Trimester 2, 2025, driven by strong demand and new course offerings amid a shifting regulatory landscape.

Classic Minerals Limited has issued a prospectus for a nominal share offer aimed at removing trading restrictions on placement shares issued to creditors, while navigating significant financial challenges and ongoing litigation over key tenements.

Titan Minerals Limited has launched a transaction-specific prospectus offering 4 million new options to its underwriter, exercisable at A$0.70 and expiring in January 2027. The offer, which raises no immediate funds, could inject approximately A$2.8 million upon option exercise.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.

Cauldron Energy has launched a fully underwritten entitlement offer to raise nearly $2 million, aiming to advance its Yanrey Uranium Project amid growing global uranium demand and hopes for regulatory change in Western Australia.